Daewoong to explore an antibiotic alternative therapy.
Published: 2005-08-22 06:59:00
Updated: 2005-08-22 06:59:00
Daewoong made a joint research agreement on July 29 with HeptoGene, a scottish venture company specialized in antibiotic products, for the development of an antibiotic alternative products using human antibodies for the first time in Korea.
The agreement indicated that both companies would dev...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
